Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Salt Lake City, USA
423 Wakara Way
Suite 200
Salt Lake City, UT, 84108


President & CEO
Chief Commercialization Officer




Lineagen ( is a provider of diagnostic and healthcare services focused on complex diseases for which individuals genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have a significant positive impact. The Company’s comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen’s commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS and COPD. One of the company’s core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world.

Recent Milestones



Lineagen screenshot
Above: Lineagen
Uploaded: 2/11/13


  1. SEC ( [edit]
  2. Lineagen, Inc. Closes $5 Million to Complete $10.8 Million Series A Round ( [edit]
  3. Lineagen to Complete $15M Series B Equity Funding Round ( [edit]
  4. SEC ( [edit]
  5. Lineagen Raises Financings ( [edit]
Edit This Page
Last Edited 1/2/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy